位置:首页 > 蛋白库 > ECEL1_HUMAN
ECEL1_HUMAN
ID   ECEL1_HUMAN             Reviewed;         775 AA.
AC   O95672; Q45UD9; Q53RF9; Q6UW86; Q86TH4; Q9NY95;
DT   27-MAR-2002, integrated into UniProtKB/Swiss-Prot.
DT   21-MAR-2006, sequence version 3.
DT   03-AUG-2022, entry version 175.
DE   RecName: Full=Endothelin-converting enzyme-like 1;
DE            EC=3.4.24.-;
DE   AltName: Full=Xce protein;
GN   Name=ECEL1; Synonyms=XCE; ORFNames=UNQ2431/PRO4991;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT TYR-328.
RC   TISSUE=Caudate nucleus, and Spinal cord;
RX   PubMed=9931490; DOI=10.1016/s0169-328x(98)00321-0;
RA   Valdenaire O., Richards J.G., Faull R.L.M., Schweizer A.;
RT   "XCE, a new member of the endothelin-converting enzyme and neutral
RT   endopeptidase family, is preferentially expressed in the CNS.";
RL   Brain Res. Mol. Brain Res. 64:211-221(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT TYR-328.
RX   PubMed=10698686; DOI=10.1042/bj3460611;
RA   Valdenaire O., Rohrbacher E., Langeveld A., Schweizer A., Meijers C.;
RT   "Organization and chromosomal localization of the human ECEL1 (XCE) gene
RT   encoding a zinc metallopeptidase involved in the nervous control of
RT   respiration.";
RL   Biochem. J. 346:611-616(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND VARIANT TYR-328.
RA   Lin L., Nong W., Zhou G., Ke R., Shen C., Zhong G., Zheng Z., Liang M.,
RA   Huang B., Li H., Yang S.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TYR-328.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT TYR-328.
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   VARIANT DA5D SER-418.
RX   PubMed=23261301; DOI=10.1016/j.ajhg.2012.11.014;
RG   University of Washington Center for Mendelian Genomics;
RA   McMillin M.J., Below J.E., Shively K.M., Beck A.E., Gildersleeve H.I.,
RA   Pinner J., Gogola G.R., Hecht J.T., Grange D.K., Harris D.J., Earl D.L.,
RA   Jagadeesh S., Mehta S.G., Robertson S.P., Swanson J.M., Faustman E.M.,
RA   Mefford H.C., Shendure J., Nickerson D.A., Bamshad M.J.;
RT   "Mutations in ECEL1 cause distal arthrogryposis type 5D.";
RL   Am. J. Hum. Genet. 92:150-156(2013).
RN   [8]
RP   VARIANT DA5D SER-607.
RX   PubMed=23808592; DOI=10.1111/cge.12224;
RA   Shaaban S., Duzcan F., Yildirim C., Chan W.M., Andrews C., Akarsu N.,
RA   Engle E.;
RT   "Expanding the phenotypic spectrum of ECEL1-related congenital contracture
RT   syndromes.";
RL   Clin. Genet. 85:562-567(2014).
RN   [9]
RP   VARIANT DA5D CYS-404.
RX   PubMed=23829171; DOI=10.1111/cge.12226;
RA   Shaheen R., Al-Owain M., Khan A., Zaki M., Hossni H., Al-Tassan R.,
RA   Eyaid W., Alkuraya F.;
RT   "Identification of three novel ECEL1 mutations in three families with
RT   distal arthrogryposis type 5D.";
RL   Clin. Genet. 85:568-572(2014).
RN   [10]
RP   VARIANT DA5D ARG-760.
RX   PubMed=23236030; DOI=10.1093/hmg/dds514;
RA   Dieterich K., Quijano-Roy S., Monnier N., Zhou J., Faure J., Smirnow D.A.,
RA   Carlier R., Laroche C., Marcorelles P., Mercier S., Megarbane A., Odent S.,
RA   Romero N., Sternberg D., Marty I., Estournet B., Jouk P.S., Melki J.,
RA   Lunardi J.;
RT   "The neuronal endopeptidase ECEL1 is associated with a distinct form of
RT   recessive distal arthrogryposis.";
RL   Hum. Mol. Genet. 22:1483-1492(2013).
CC   -!- FUNCTION: May contribute to the degradation of peptide hormones and be
CC       involved in the inactivation of neuronal peptides.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion. {ECO:0000250};
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000250}; Single-pass type II
CC       membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O95672-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O95672-2; Sequence=VSP_017544;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the CNS, in particular in
CC       putamen, spinal cord, medulla and subthalamic nucleus. A strong signal
CC       was also detected in uterine subepithelial cells and around renal blood
CC       vessels. Detected at lower levels in amygdala, caudate, thalamus,
CC       pancreas and skeletal muscle. Detected at very low levels in substantia
CC       nigra, cerebellum, cortex, corpus callosum and hippocampus.
CC   -!- PTM: N-glycosylated.
CC   -!- DISEASE: Arthrogryposis, distal, 5D (DA5D) [MIM:615065]: An autosomal
CC       recessive form of distal arthrogryposis, a disease characterized by
CC       congenital joint contractures that mainly involve two or more distal
CC       parts of the limbs, in the absence of a primary neurological or muscle
CC       disease. DA5D is characterized by severe camptodactyly of the hands,
CC       mild camptodactyly of the toes, clubfoot and/or a calcaneovalgus
CC       deformity, extension contractures of the knee, unilateral ptosis or
CC       ptosis that is more severe on one side, a round-shaped face, arched
CC       eyebrows, a bulbous upturned nose, and micrognathia. Patients do not
CC       have ophthalmoplegia. {ECO:0000269|PubMed:23236030,
CC       ECO:0000269|PubMed:23261301, ECO:0000269|PubMed:23808592,
CC       ECO:0000269|PubMed:23829171}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry. ECEL1 mutations have also
CC       been found in patients with arthrogryposis, significant
CC       ophthalmoplegia, and refractive errors (PubMed:23808592).
CC       {ECO:0000269|PubMed:23808592}.
CC   -!- SIMILARITY: Belongs to the peptidase M13 family. {ECO:0000255|PROSITE-
CC       ProRule:PRU01233, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y16187; CAA76113.1; -; mRNA.
DR   EMBL; AJ130734; CAB86601.1; -; Genomic_DNA.
DR   EMBL; DQ114476; AAZ22338.1; -; mRNA.
DR   EMBL; AY358923; AAQ89282.1; -; mRNA.
DR   EMBL; AC092165; AAY24101.1; -; Genomic_DNA.
DR   EMBL; BC050453; AAH50453.2; -; mRNA.
DR   CCDS; CCDS2493.1; -. [O95672-1]
DR   CCDS; CCDS77540.1; -. [O95672-2]
DR   RefSeq; NP_001277716.1; NM_001290787.1. [O95672-2]
DR   RefSeq; NP_004817.2; NM_004826.3. [O95672-1]
DR   AlphaFoldDB; O95672; -.
DR   SMR; O95672; -.
DR   BioGRID; 114820; 149.
DR   IntAct; O95672; 9.
DR   STRING; 9606.ENSP00000302051; -.
DR   MEROPS; M13.007; -.
DR   GlyGen; O95672; 3 sites.
DR   iPTMnet; O95672; -.
DR   PhosphoSitePlus; O95672; -.
DR   BioMuta; ECEL1; -.
DR   EPD; O95672; -.
DR   MassIVE; O95672; -.
DR   MaxQB; O95672; -.
DR   PaxDb; O95672; -.
DR   PeptideAtlas; O95672; -.
DR   PRIDE; O95672; -.
DR   ProteomicsDB; 50986; -. [O95672-1]
DR   ProteomicsDB; 50987; -. [O95672-2]
DR   Antibodypedia; 47689; 53 antibodies from 13 providers.
DR   DNASU; 9427; -.
DR   Ensembl; ENST00000304546.6; ENSP00000302051.1; ENSG00000171551.12. [O95672-1]
DR   Ensembl; ENST00000409941.1; ENSP00000386333.1; ENSG00000171551.12. [O95672-2]
DR   GeneID; 9427; -.
DR   KEGG; hsa:9427; -.
DR   MANE-Select; ENST00000304546.6; ENSP00000302051.1; NM_004826.4; NP_004817.2.
DR   UCSC; uc002vsv.3; human. [O95672-1]
DR   CTD; 9427; -.
DR   DisGeNET; 9427; -.
DR   GeneCards; ECEL1; -.
DR   HGNC; HGNC:3147; ECEL1.
DR   HPA; ENSG00000171551; Group enriched (brain, ovary, pituitary gland).
DR   MalaCards; ECEL1; -.
DR   MIM; 605896; gene.
DR   MIM; 615065; phenotype.
DR   neXtProt; NX_O95672; -.
DR   OpenTargets; ENSG00000171551; -.
DR   Orphanet; 329457; Distal arthrogryposis type 5D.
DR   PharmGKB; PA27595; -.
DR   VEuPathDB; HostDB:ENSG00000171551; -.
DR   eggNOG; KOG3624; Eukaryota.
DR   GeneTree; ENSGT00940000157673; -.
DR   HOGENOM; CLU_006187_8_0_1; -.
DR   InParanoid; O95672; -.
DR   OMA; MHKVSDL; -.
DR   OrthoDB; 282463at2759; -.
DR   PhylomeDB; O95672; -.
DR   TreeFam; TF315192; -.
DR   PathwayCommons; O95672; -.
DR   SignaLink; O95672; -.
DR   BioGRID-ORCS; 9427; 10 hits in 1068 CRISPR screens.
DR   GeneWiki; ECEL1; -.
DR   GenomeRNAi; 9427; -.
DR   Pharos; O95672; Tbio.
DR   PRO; PR:O95672; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; O95672; protein.
DR   Bgee; ENSG00000171551; Expressed in left ovary and 102 other tissues.
DR   ExpressionAtlas; O95672; baseline and differential.
DR   Genevisible; O95672; HS.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004222; F:metalloendopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008237; F:metallopeptidase activity; TAS:ProtInc.
DR   GO; GO:0007218; P:neuropeptide signaling pathway; TAS:ProtInc.
DR   GO; GO:0016485; P:protein processing; IBA:GO_Central.
DR   GO; GO:0003016; P:respiratory system process; ISS:UniProtKB.
DR   CDD; cd08662; M13; 1.
DR   Gene3D; 1.10.1380.10; -; 1.
DR   Gene3D; 3.40.390.10; -; 1.
DR   InterPro; IPR029736; ECEL1.
DR   InterPro; IPR024079; MetalloPept_cat_dom_sf.
DR   InterPro; IPR000718; Peptidase_M13.
DR   InterPro; IPR018497; Peptidase_M13_C.
DR   InterPro; IPR042089; Peptidase_M13_dom_2.
DR   InterPro; IPR008753; Peptidase_M13_N.
DR   PANTHER; PTHR11733; PTHR11733; 1.
DR   PANTHER; PTHR11733:SF195; PTHR11733:SF195; 1.
DR   Pfam; PF01431; Peptidase_M13; 1.
DR   Pfam; PF05649; Peptidase_M13_N; 1.
DR   PRINTS; PR00786; NEPRILYSIN.
DR   PROSITE; PS51885; NEPRILYSIN; 1.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Disulfide bond; Glycoprotein;
KW   Hydrolase; Membrane; Metal-binding; Metalloprotease; Protease;
KW   Reference proteome; Signal-anchor; Transmembrane; Transmembrane helix;
KW   Zinc.
FT   CHAIN           1..775
FT                   /note="Endothelin-converting enzyme-like 1"
FT                   /id="PRO_0000078224"
FT   TOPO_DOM        1..59
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        60..82
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        83..775
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          98..775
FT                   /note="Peptidase M13"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   ACT_SITE        613
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   ACT_SITE        676
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   BINDING         612
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         616
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233,
FT                   ECO:0000255|PROSITE-ProRule:PRU10095"
FT   BINDING         672
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   CARBOHYD        255
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        322
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        656
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        123..760
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        131..720
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        187..441
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   DISULFID        649..772
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01233"
FT   VAR_SEQ         561..562
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_017544"
FT   VARIANT         10
FT                   /note="H -> Q (in dbSNP:rs2741281)"
FT                   /id="VAR_012813"
FT   VARIANT         328
FT                   /note="H -> Y (in dbSNP:rs1529874)"
FT                   /evidence="ECO:0000269|PubMed:10698686,
FT                   ECO:0000269|PubMed:12975309, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9931490, ECO:0000269|Ref.3"
FT                   /id="VAR_012814"
FT   VARIANT         404
FT                   /note="R -> C (in DA5D; dbSNP:rs532757890)"
FT                   /evidence="ECO:0000269|PubMed:23829171"
FT                   /id="VAR_069993"
FT   VARIANT         418
FT                   /note="R -> S (in DA5D; dbSNP:rs587776919)"
FT                   /evidence="ECO:0000269|PubMed:23261301"
FT                   /id="VAR_069747"
FT   VARIANT         607
FT                   /note="G -> S (in DA5D; patients have ophthalmoplegia)"
FT                   /evidence="ECO:0000269|PubMed:23808592"
FT                   /id="VAR_069994"
FT   VARIANT         760
FT                   /note="C -> R (in DA5D; dbSNP:rs587777129)"
FT                   /evidence="ECO:0000269|PubMed:23236030"
FT                   /id="VAR_069995"
FT   CONFLICT        45
FT                   /note="A -> V (in Ref. 4; AAQ89282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124
FT                   /note="Q -> R (in Ref. 3; AAZ22338)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        152
FT                   /note="A -> T (in Ref. 3; AAZ22338)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        163
FT                   /note="R -> C (in Ref. 3; AAZ22338)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        286
FT                   /note="I -> V (in Ref. 1; CAA76113)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        293
FT                   /note="F -> L (in Ref. 3; AAZ22338)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        544
FT                   /note="R -> P (in Ref. 4; AAQ89282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        679
FT                   /note="G -> V (in Ref. 4; AAQ89282)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        757..758
FT                   /note="AF -> VL (in Ref. 1; CAA76113)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        763
FT                   /note="D -> V (in Ref. 1; CAA76113)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   775 AA;  87791 MW;  C4ED98DE848BE822 CRC64;
     MEPPYSLTAH YDEFQEVKYV SRCGAGGARG ASLPPGFPLG AARSATGARS GLPRWNRREV
     CLLSGLVFAA GLCAILAAML ALKYLGPVAA GGGACPEGCP ERKAFARAAR FLAANLDASI
     DPCQDFYSFA CGGWLRRHAI PDDKLTYGTI AAIGEQNEER LRRLLARPGG GPGGAAQRKV
     RAFFRSCLDM REIERLGPRP MLEVIEDCGG WDLGGAEERP GVAARWDLNR LLYKAQGVYS
     AAALFSLTVS LDDRNSSRYV IRIDQDGLTL PERTLYLAQD EDSEKILAAY RVFMERVLSL
     LGADAVEQKA QEILQVEQQL ANITVSEHDD LRRDVSSMYN KVTLGQLQKI TPHLRWKWLL
     DQIFQEDFSE EEEVVLLATD YMQQVSQLIR STPHRVLHNY LVWRVVVVLS EHLSPPFREA
     LHELAQEMEG SDKPQELARV CLGQANRHFG MALGALFVHE HFSAASKAKV QQLVEDIKYI
     LGQRLEELDW MDAETRAAAR AKLQYMMVMV GYPDFLLKPD AVDKEYEFEV HEKTYFKNIL
     NSIRFSIQLS VKKIRQEVDK STWLLPPQAL NAYYLPNKNQ MVFPAGILQP TLYDPDFPQS
     LNYGGIGTII GHELTHGYDD WGGQYDRSGN LLHWWTEASY SRFLRKAECI VRLYDNFTVY
     NQRVNGKHTL GENIADMGGL KLAYHAYQKW VREHGPEHPL PRLKYTHDQL FFIAFAQNWC
     IKRRSQSIYL QVLTDKHAPE HYRVLGSVSQ FEEFGRAFHC PKDSPMNPAH KCSVW
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024